Compile Data Set for Download or QSAR
maximum 50k data
Found 720 with Last Name = 'brain' and Initial = 'c'
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254456(CHEMBL447392 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  11nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254457(CHEMBL443207 | N-(2-chlorobenzyl)-2-(N-(3-chloro-4...)
Affinity DataKi:  21nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254458(CHEMBL452238 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  34nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254456(CHEMBL447392 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  37nMAssay Description:Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254459(CHEMBL512111 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  93nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254460(CHEMBL499999 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  113nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254461(CHEMBL507546 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  149nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254457(CHEMBL443207 | N-(2-chlorobenzyl)-2-(N-(3-chloro-4...)
Affinity DataKi:  188nMAssay Description:Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254462(CHEMBL468492 | N-(2-methoxyphenethyl)-2-(N-(2-(ben...)
Affinity DataKi:  210nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254458(CHEMBL452238 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  267nMAssay Description:Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254463(3-(2-(2,4-dichloro-N-(2-(2,3-dihydro-1H-inden-5-yl...)
Affinity DataKi:  410nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254461(CHEMBL507546 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  463nMAssay Description:Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254459(CHEMBL512111 | N-(2-chlorobenzyl)-2-(N-(4-isobutox...)
Affinity DataKi:  497nMAssay Description:Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254508(3-(2-(2,4-dichloro-N-(2-(3-chlorophenoxy)ethyl)phe...)
Affinity DataKi:  1.09E+3nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254632(2-(2,4-dichloro-N-(2-(2,3-dihydro-1H-inden-5-yloxy...)
Affinity DataKi:  1.21E+3nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254633(3-(2-(N-(2-(benzo[d][1,3]dioxol-5-yloxy)ethyl)-2,4...)
Affinity DataKi:  1.57E+3nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254634(2-(2,4-dichloro-N-(2-(2,3-dihydro-1H-inden-5-yloxy...)
Affinity DataKi:  2.20E+3nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetB1 bradykinin receptor(Homo sapiens (Human))
Pharmacopeia

Curated by ChEMBL
LigandPNGBDBM50254635(3-(2-(2,4-dichloro-N-(2-phenoxyethyl)phenylsulfona...)
Affinity DataKi:  1.30E+4nMAssay Description:Displacement of [3H]desArg from human B1 in human WI 38 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)
Affinity DataIC50:  0.770nMAssay Description:Displacement of [3H]CP-55940 from human CB1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146964(US8957074, 3)
Affinity DataIC50:  1nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)
Affinity DataIC50:  1.30nMAssay Description:Displacement of [3H]CP-55940 human CB2 receptor expressed in CHOK1 cellsMore data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147014(US8957074, 53)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147083(US8957074, 123)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147027(US8957074, 67)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Oryctolagus cuniculus (Rabbit))
Astex Therapeutics

US Patent
LigandPNGBDBM50420304(CHEMBL2089065 | US8598217, 165)
Affinity DataIC50:  3nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147049(US8957074, 89)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146997(US8957074, 36)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147041(US8957074, 83)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147015(US8957074, 54)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50492297(CHEMBL2397751)
Affinity DataIC50:  3.5nMAssay Description:Agonist activity at CB2 receptor (unknown origin)More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146970(US8957074, 9)
Affinity DataIC50: <4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146965(US8957074, 4)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147091(US8957074, 131)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Oryctolagus cuniculus (Rabbit))
Astex Therapeutics

US Patent
LigandPNGBDBM107755(US8598217, 140)
Affinity DataIC50:  4nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147042(US8957074, 82)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Oryctolagus cuniculus (Rabbit))
Astex Therapeutics

US Patent
LigandPNGBDBM107751(CHEMBL2089063 | US8598217, 89)
Affinity DataIC50:  4nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50330271(CHEMBL1271620 | [4-(3-Isopropyl-1H-pyrazol-4-yl)-p...)
Affinity DataIC50: <5nMAssay Description:Inhibition of human CDK4/cyclin D1 expressed in baculovirus infected Sf21 cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146963(US8957074, 2)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Oryctolagus cuniculus (Rabbit))
Astex Therapeutics

US Patent
LigandPNGBDBM107761(US8598217, 174)
Affinity DataIC50:  5nMpH: 7.5Assay Description:A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM47154(US8957074, 81)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146971(US8957074, 10)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147093(US8957074, 133)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147087(US8957074, 127)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147053(US8957074, 93)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147050(US8957074, 90)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147044(US8957074, 84 | US8957074, 86)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147047(US8957074, 87)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147048(US8957074, 88)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146998(US8957074, 37)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147026(US8957074, 66)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 720 total ) | Next | Last >>
Jump to: